Cargando…

Lower Limb Muscle Strength and Muscle Mass Are Associated With Incident Symptomatic Knee Osteoarthritis: A Longitudinal Cohort Study

Recent literature suggests that sarcopenia, often represented by low lower limbs muscle mass and strength, can be considered a potential risk factor for knee osteoarthritis (OA), but the available literature is still limited. We therefore aimed to investigate whether sarcopenia is associated with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veronese, Nicola, Stefanac, Sinisa, Koyanagi, Ai, Al-Daghri, Nasser M., Sabico, Shaun, Cooper, Cyrus, Rizzoli, Renè, Reginster, Jean-Yves, Barbagallo, Mario, Dominguez, Ligia J., Smith, Lee, Maggi, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716541/ https://www.ncbi.nlm.nih.gov/pubmed/34975772 http://dx.doi.org/10.3389/fendo.2021.804560

Ejemplares similares

Knee osteoarthritis and adverse health outcomes: an umbrella review of meta-analyses of observational studies
por: Veronese, Nicola, et al.
Publicado: (2022)

Dynapenic abdominal obesity and susceptibility to fall: a prospective analysis of the Osteoarthritis Initiative
por: Veronese, Nicola, et al.
Publicado: (2023)

Multidimensional prognostic index and the risk of fractures: an 8-year longitudinal cohort study in the Osteoarthritis Initiative
por: Veronese, Nicola, et al.
Publicado: (2021)

Influenza Vaccination and COVID-19 Outcomes in People Older than 50 Years: Data from the Observational Longitudinal SHARE Study
por: Veronese, Nicola, et al.
Publicado: (2022)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
por: Bruyère, Olivier, et al.
Publicado: (2008)

Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis
por: Beaudart, Charlotte, et al.
Publicado: (2023)

Measures of attributes of locomotor capacity in older people: a systematic literature review following the COSMIN methodology
por: Honvo, Germain, et al.
Publicado: (2023)

Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study
por: Veronese, Nicola, et al.
Publicado: (2022)

Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Honvo, Germain, et al.
Publicado: (2019)

Sarcopenia reduces quality of life in the long-term: longitudinal analyses from the English longitudinal study of ageing
por: Veronese, Nicola, et al.
Publicado: (2022)

Dietary acrylamide and incident osteoporotic fractures: an 8-year prospective cohort study
por: Veronese, Nicola, et al.
Publicado: (2022)

Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO)
por: Al-Daghri, Nasser M., et al.
Publicado: (2016)

Vitamin D level and its relation to muscle and fat mass in adult male Arabs
por: Yakout, Sobhy M., et al.
Publicado: (2020)

Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
por: Cooper, Cyrus, et al.
Publicado: (2019)

Dietary Magnesium and Incident Frailty in Older People at Risk for Knee Osteoarthritis: An Eight-Year Longitudinal Study
por: Veronese, Nicola, et al.
Publicado: (2017)

The role of interleukin-1β in type 2 diabetes mellitus: A systematic review and meta-analysis
por: Alfadul, Hend, et al.
Publicado: (2022)

Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis
por: Honvo, Germain, et al.
Publicado: (2019)

Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment
por: Reginster, Jean-Yves, et al.
Publicado: (2020)

Effect of Calcifediol on Physical Performance and Muscle Strength Parameters: A Systematic Review and Meta-Analysis
por: Barbagallo, Mario, et al.
Publicado: (2022)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

Mitochondrial genetic haplogroups and cardiovascular diseases: Data from the Osteoarthritis Initiative
por: Veronese, Nicola, et al.
Publicado: (2019)

Improved HDL Cholesterol through Vitamin D Status Correction Substantially Lowers 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Vitamin D-Deficient Arab Adults
por: Sabico, Shaun, et al.
Publicado: (2023)

Pitfalls in the measurement of muscle mass: a need for a reference standard
por: Buckinx, Fanny, et al.
Publicado: (2018)

Mindful Exercise (Baduanjin) as an Adjuvant Treatment for Older Adults (60 Years Old and Over) of Knee Osteoarthritis: A Randomized Controlled Trial
por: Ye, JiaJia, et al.
Publicado: (2020)

Dynapenic abdominal obesity and incident multimorbidity: findings from the English longitudinal study on ageing
por: Veronese, Nicola, et al.
Publicado: (2023)

Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice
por: Cooper, Cyrus, et al.
Publicado: (2017)

Establishing abdominal height cut-offs and their association with conventional indices of obesity among Arab children and adolescents
por: Al-Daghri, Nasser, et al.
Publicado: (2010)

Editorial: Diseases in the COVID-19 epidemic
por: Veronese, Nicola, et al.
Publicado: (2023)

Magnesium and Hypertension in Old Age
por: Dominguez, Ligia J., et al.
Publicado: (2020)

Magnesium in Aging, Health and Diseases
por: Barbagallo, Mario, et al.
Publicado: (2021)

Magnesium in Type 2 Diabetes Mellitus, Obesity, and Metabolic Syndrome
por: Barbagallo, Mario, et al.
Publicado: (2022)

Magnesium—An Ion with Multiple Invaluable Actions, Often Insufficiently Supplied: From In Vitro to Clinical Research
por: Barbagallo, Mario, et al.
Publicado: (2023)

Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients
por: Al-Daghri, Nasser M., et al.
Publicado: (2017)

Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders
por: Wani, Kaiser, et al.
Publicado: (2021)

Circulating Nitric Oxide and Metabolic Syndrome in Arab Children and Adolescents: A Case–Control Study
por: Amer, Osama E., et al.
Publicado: (2023)

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Diez-Perez, Adolfo, et al.
Publicado: (2019)

The Authors reply: “Dual energy X‐ray absorptiometry: gold standard for muscle mass?” by Scafoglieri et al.
por: Buckinx, Fanny, et al.
Publicado: (2018)

Prevalence of unwillingness and uncertainty to vaccinate against COVID-19 in older people: A systematic review and meta-analysis
por: Veronese, Nicola, et al.
Publicado: (2021)

The authors reply: Letter on: “Pitfalls in the measurement of muscle mass: a need for a reference standard” by Clark et al.
por: Buckinx, Fanny, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_90iqrp24h1lnddqbblabo017hc